PTK787/ZK 222584 in Treating Patients With Unresectable Malignant Mesothelioma
Study Information
Alliance Study ID: CALGB-30107
NCT Study ID (ClinicalTrials.gov): NCT00053885
Alliance Committee: Respiratory Cancer
Disease or Cancer Type: Lung Cancer & Mesothelioma
Alliance Study Chair: Thierry Jahan, MD
Status: COMPLETED
Study Description
RATIONALE: PTK787/ZK 222584 may stop the growth of tumor cells by blocking the enzymes necessary for tumor cell growth.
PURPOSE: Phase II trial to study the effectiveness of PTK787/ZK 222584 in treating patients with unresectable malignant mesothelioma.
Related Publications
For publications related to this and other clinical trials, visit the Alliance Publications Application.
Data Sources & Contacts
Full trial details
For more Information